We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-3.54%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$20.7B
AUM Growth
+$696M
Cap. Flow
+$853M
Cap. Flow %
4.12%
Top 10 Hldgs %
37.98%
Holding
357
New
50
Increased
42
Reduced
43
Closed
37

Sector Composition

Rank Sector Weight
1 Healthcare 28.91%
2 Technology 15.84%
3 Financials 13.74%
4 Industrials 11.77%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANA
151
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$7.33M 0.04%
750,000
RACB
152
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$7.32M 0.04%
750,000
ARYE
153
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$7.24M 0.04%
745,000
GIIX
154
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
$6.89M 0.03%
692,810
KVSA
155
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$6.85M 0.03%
700,000
STRE
156
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
$6.85M 0.03%
700,000
CORS
157
DELISTED
Corsair Partnering Corporation
CORS
$6.8M 0.03%
700,000
RCEL icon
158
Avita Medical
RCEL
$240M
$6.78M 0.03%
800,000
ARWR icon
159
Arrowhead Research
ARWR
$12.4B
$6.56M 0.03%
142,700
-177,917
-55% -$8.81M
COGT icon
160
Cogent Biosciences
COGT
$7.24B
$6.37M 0.03%
850,000
+250,000
+42% +$1.74M
RKTA
161
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
$6.34M 0.03%
647,945
CLVR
162
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$6.07M 0.03%
81,214
-20,448
-20% -$1.11M
THRX
163
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$6.04M 0.03%
523,979
RCFA
164
DELISTED
Perception Capital Corp. IV
RCFA
$5.96M 0.03%
+600,000
New +$5.93M
GBT
165
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.87M 0.03%
169,458
+83,004
+96% +$2.48M
FSRX
166
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$5.86M 0.03%
600,000
IPVI
167
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
$5.85M 0.03%
600,000
BWC
168
DELISTED
Blue Whale Acquisition Corp I Class A Ordinary Shares
BWC
$5.58M 0.03%
575,000
SLAM
169
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$5.57M 0.03%
570,396
PNT
170
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$4.99M 0.02%
626,322
-1,080,007
-63% -$6.86M
GSQD
171
DELISTED
G Squared Ascend I Inc.
GSQD
$4.92M 0.02%
500,000
TIOA
172
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
$4.92M 0.02%
502,001
HERA
173
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$4.89M 0.02%
500,000
GHIX
174
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$4.89M 0.02%
+500,000
New +$4.85M
CLAA
175
DELISTED
Colonnade Acquisition Corp. II
CLAA
$4.88M 0.02%
500,000

Similar funds

Farallon Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Farallon Capital Management held 357 positions worth $20.7B, up 3.5% from $20B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Farallon Capital Management deployed $853M of net new capital in Q1 2022, opening 50 new positions and adding to 42 existing holdings. Its largest new stake was ZYNGA INC. CL A COMMON: 44,475,000 shares worth $411M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was RTX Corp, an estimated $227M trimmed.

  • Farallon Capital Management's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 44,475,000 shares worth $411M.
  • Farallon Capital Management added most to TransUnion in Q1 2022, an estimated $345M increase.
  • Farallon Capital Management's biggest Q1 2022 reduction was RTX Corp, cutting an estimated $227M.
  • Farallon Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $561M.
  • Farallon Capital Management's ten largest holdings make up 38% of its $20.7B portfolio in Q1 2022.
  • Farallon Capital Management opened 50 new positions and closed 37 in Q1 2022.
  • Farallon Capital Management's portfolio value rose 3.5% quarter-over-quarter to $20.7B.

Based on Farallon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.